Grants and Contributions:
Title:
Scale-up of a medical technology to treat breast cancer and its preclinical validation to treat breast cancer and skin cancer.
Agreement Number:
1034054
Agreement Value:
$197,000.00
Agreement Date:
May 26, 2025 - Mar 31, 2027
Description:
The project involves the conceptual design of the pre-production applicator and its in vitro testing for breast cancer, followed by the conceptual design of the pre-production control unit.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Montreal, Quebec, CA H4A 2T7
Reference Number:
172-2025-2026-Q2-1034054
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
819165614
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 32,000 dollars.
Amendment Date
Apr 20, 2026
Recipient's Legal Name:
NexPlasmaGen Incorporée
Federal Riding Name:
Notre-Dame-de-Grâce--Westmount
Federal Riding Number:
24053
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
339110
Amendments: